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INTRODUCTION
Scleredema, originally described by Buschke in 1902 (1),
is a rare sclerodermatosis of unknown etiology, which is char-
acterized by wooden, nonpitting induration of the skin. In
general, scleredema first affects the face and neck, and then
may spread symmetrically to the shoulders, trunk, arms, and
legs: however, the hands and feet are usually unaffected. The
disease has occasionally been found in association with a mon-
oclonal gammopathy (MG), in which serum immunoglobu-
lins are usually of the IgG type and the chains are either of
the kappa or lambda type (2-6). On the other hand, anky-
losing spondylitis (AS) is a chronic systemic inflammatory
disorder of the axial skeleton, mainly affecting the sacroiliac
joint and spine, and the association of AS with MG has also
been described in the literature (7). To the best of our knowl-
edge, there have been no reports on patients with scleredema
and AS accompanied with a MG. We here report a male pa-
tient with scleredema and advanced AS accompanied with a
MG of IgA-kappa protein.
CASE REPORT
A 40-yr-old man presented with a 7-yr history of a wide-
spread skin thickening, initially noted on the posterior aspect
of the neck. He had no history of diabetes mellitus or preced-
ing upper respiratory tract infection. Raynaud phenomenon
and dysphagia were not noted. The pain and stiffness in the
lower lumbar region and buttock had begun since the age of
24 yr and had been worse in the morning and improved with
activity. Physical examination disclosed a symmetric woody
induration of the skin on the face, neck, shoulders, trunk, arms,
and legs (Fig. 1). His hands and feet were spared. Facial expres-
sion was lost: however, the tongue was not enlarged and the
frenulum of the tongue was normal. There were no nodules
in the skin. In addition, there was marked restriction of lum-
bar and cervical spine movements. The chest expansion at the
fourth intercostal space and modified Schober test were 3.5
cm and 2 cm, respectively. Otherwise, the remaining physical
examination was unremarkable. 
The blood counts, ESR, calcium, urinalysis, glucose toler-
ance test, and antistreptolysin O titer were normal. There were
no abnormalities in chemistry except that the ratio of albumin
vs. globulin was reversed, as albumin 3.7 g/dL vs. globulin
4.4 g/dL. Antinuclear antibody was negative, and HLA-B27
was positive. The IgA level was elevated to 2,084 mg/dL (nor-
mal, 70-400): IgG and IgM values were normal. Serum pro-
tein electrophoresis revealed a spike in beta globulin fraction,
and serum immunoelectrophoresis showed a monoclonal IgA-
kappa protein. Bence-Jones proteinuria was absent. Bone mar-
row examination revealed no evidences for multiple myeloma.
Radiology of the spine and pelvis showed features of advanc-
ed AS, including near total ankylosis of bilateral sacroiliac
joints and a bamboo spine appearance (Fig. 2). There were no
osteolytic lesions on the skeletal survey. Histology of a skin
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Widespread Scleredema Accompanied with a Monoclonal Gammopathy
in a Patient with Advanced Ankylosing Spondylitis
Scleredema is a rare cutaneous mucinosis characterized by chronic diffuse indura-
tion of the skin, and it is occasionally associated with a monoclonal gammopathy
(MG). Ankylosing spondylitis (AS) is noted to be another, chronic systemic inflam-
matory disorder of the axial skeleton that may accompany the MG. However, patients
with scleredema and AS accompanied with a MG have not been reported in the lit-
erature. We here report a 40-yr-old man with scleredema and advanced AS accom-
panied with a MG of IgA-kappa protein. Widespread, long-standing scleredema has
been developed over 10 yrs after the initial manifestation of AS. It is uncertain whether
the coexistence of scleredema and AS is more than coincidental.
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biopsy taken from the arm revealed normal epidermis and a
markedly thickened dermis. The collagen bundles were thick-
ened and separated from one another. Alcian blue stain demon-
strated abundant mucin deposits between collagen bundles
(Fig. 3). The diagnosis of scleredema and AS with a MG was
established. After the nature and clinical course of the disease
were explained, the patient refused to undergo further treat-
ment, except for nonsteroidal anti-inflammatory drugs.
DISCUSSION
Based on the clinical and histological features, scleredema
can be differentiated from other conditions associated with
the skin induration, such as systemic sclerosis and scleromy-
xedema. In contrast to patients with systemic sclerosis, the
patients with scleredema usually have no evidences of Ray-
naud phenomenon, acral sclerosis, and thickening of the frenu-
lum of the tongue, as well as negative ANA test. Although
scleromyxedema, another skin condition mimicking sclere-
dema, is also noted to be associated with a MG or multiple
myeloma, it progresses acrally and presents characteristic large
folds or papules, which are not clinical features associated with
scleredema (2, 4, 5, 8, 9). Moreover, the scleredema shows
histological features different from other skin diseases, in which
the dermis is markedly thickened and collagen bundles are
characteristically separated from each other by large fenestra-
tion with variable amounts of mucin (5, 10). The clinical and
histological findings of our patient were compatible with the
scleredema. The diagnosis of AS in this patient was made by
the clinical findings and radiological features showing advanc-
ed, bilateral sacroiliitis.
Three clinical groups of scleredema have been recognized
by Graff (11): in the first group, the disease starts abruptly
after an acute upper respiratory tract infection, having a ten-
dency to resolve in a period of months to years; the second
group begins insidiously without preceding respiratory tract
infection and has longer duration over a period of years; the
third group is of a long-standing scleredema associated with
severe complicated diabetes mellitus. According to this clas-
Fig. 3. (A) The collagen bundles are thickened and separated by clear spaces leading to fenestrations of the collagen (hematoxylin and
eosin, ×200). (B) Mucin deposits are present between the collagen bundles (Alcian blue stain, ×200).
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Fig. 1. There is a marked induration of the skin on the posterior neck.
Fig. 2. The radiograph
of lumbar spine and
pelvis shows near total
ankylosis of bilateral
sacroiliac joints and a
bamboo spine appea-
rance with bilateral syn-
desmophytes (arrows)
at the thoracolumbar
vertebrae.Scleredema, Ankylosing spondylitis and Monoclonal Gammopathy 483
sification, our patient seems to belong to the second group.
In Korea, Lee et al. reported 31 patients with scleredema, in
whom most patients showed insidious onset and chronic local-
ized lesions on the nape and upper back, and 16 patients (51.6
%) had the accompanied diabetes mellitus (12). 
In both scleredema and AS, there have been known asso-
ciations with MG and less commonly with multiple myelo-
ma (2-7, 13). Hodak et al. documented the following find-
ings in the review of the literature: in patients with sclerede-
ma and MG, the scleredema was not preceded by any infec-
tious diseases, nor was it accompanied with diabetes mellitus,
and it was usually widespread and long-standing (3). These
findings were very similar to the skin conditions of our patient.
In the case of scleredema with a MG, serum immunoglobu-
lins are usually of the IgG type, although IgA and IgM have
also been reported, and their chains are either of the kappa
or lambda type (2, 4-6). Renier et al. reported that seven
patients (1.3%) out of 557 patients with AS were found to
have MG: 5 patients with IgG, 4 of them of the lambda type,
and 2 IgM, both of the kappa type were found; no patients
with IgA were observed (7). Interestingly, the current patient
had a MG of IgA-kappa protein. 
It is unclear whether the coexistence of scleredema and AS
is more than coincidental. Mild and moderate elevations of
serum IgA levels are frequently noted in AS. Although there
is some controversy, high levels of serum IgA may be inter-
preted as evidence for mucosal infections (14). Moreover, Kleb-
siella pneumoniae, a normal gut flora, has been suggested to
be involved in the pathogenesis of AS (15, 16). Of interest,
several cases with AS, who had infectious diseases when the
MG was discovered, have been reported (7). However, our
patient had no evidences of preceding acute illness, and since
the scleredema patients with a MG usually have no preced-
ing infection (3), it is obscure whether the infectious process
would contribute to the pathogenesis in the current patient.
To date, the treatment for scleredema remains difficult, al-
though significant improvement was reported recently with
the electron-beam therapy (6, 17). As mentioned previously,
prognosis of this skin disease is variable: the disease following
an acute upper respiratory tract infection has a favorable out-
come, whereas the scleredema patients without preceding
upper respiratory infection usually have long-standing skin
disease (6, 11). Since cases with widespread long-standing
scleredema, in whom the finding of MG subsequently pro-
gressed to overt multiple myeloma, have been reported (3), a
periodic assessment in the current patient will be required.
In summary, we report a patient with both scleredema and
advanced AS who had an accompanying MG. The patient has
had a widespread, long-standing scleredema developed over
10 yrs after the initial manifestation of AS.
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